Aktiesnakken — December 2011
-
Det er da flot TORM har ubelejeliget sig med at lave finanskalender for hele 2012.
-
-
den var ond Kristensen!
-
-
BNP nedjusteres fra 2,0 til 1,8
-
jeps..
-
Så er vi oppe på 71 ofatumumab forsøg. 2nye idag! Har dog mistet overblikket over hvilke der er nye
-
To nye fase 2 forsøg med OFA+methylprednisolon og OFA+Lenalidomide i CLL
-
meget godt!
-
-
Så er Tower Group på vej til at gå konk..
-
-
".....
Skulle muligheden for udskilning mislykkes, er det usandsynligt, at Bestyrelsen
vil have andre muligheder end at begære selskabet konkurs. " -
Ikke at det var den store overraskelse, men alligevel..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind